Vivitra Trastuzumab Lyophilized Powder

Vivitra Trastuzumab Lyophilized Powder Specifications and Applications:

1. Trastuzumab, a monoclonal antibody, is a targeted therapy that binds precisely to the HER2 protein that is overexpressed in some cancer cells.

2. Breast cancer that is HER2-positive is commonly treated with Vivitra Trastuzumab, both for early-stage and metastatic cases.

3. Stomach Cancer: For cases of advanced stomach cancer that is HER2-positive, it is also utilised in conjunction with chemotherapy.

4. Lyophilized Powder: Vivitra Trastuzumab is available as a lyophilized powder that must be reconstituted before being infused intravenously.

5. Adjuvant Therapy: To lower the chance of cancer recurrence, it may be used as adjuvant therapy in early-stage breast cancer.

6. Treatment for Metastatic Breast Cancer: Vivitra Trastuzumab can prolong patient survival and assist reduce the progression of the disease in metastatic breast cancer.

7. HER2 Testing: Tumour tissue HER2 testing determines a patient's eligibility for Vivitra Trastuzumab.

8. Combination Therapy: For best treatment success, it is frequently used in conjunction with other chemotherapy drugs or targeted therapies.

9. HER2-Negative Tumours: The usage of Vivitra Trastuzumab is not recommended for HER2-negative tumours.

Vivitra Trastuzumab Lyophilized Powder Side Effects:

1. Reactions to Infusions: Some patients may encounter reactions to infusions, including fever, chills, and skin rashes.

2. Cardiotoxicity: Trastuzumab may result in problems with the heart, such as decreased heart function and heart failure.

3. Weakening of Heart Muscle: Trastuzumab has the potential to occasionally cause cardiomyopathy, a weakening of the heart muscle.

4. Diarrhoea: During treatment, gastrointestinal side effects, including diarrhoea, are possible.

5. Vomiting and Nausea: Some people may feel queasy or sick to their stomach.

6. Trastuzumab can cause neutropenia, which lowers white blood cell counts and raises the risk of infections.

7. Patients may feel weak or worn out while receiving treatment.

8. Trastuzumab may result in skin problems such as redness or itching. 

Before beginning Vivitra Trastuzumab medication, patients must discuss potential side effects and risks with their doctor. The management of adverse effects and the safe and efficient use of this medicine can be achieved through routine monitoring and appropriate medical supervision during therapy.